70511-0161 Bortezomib - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

70511-0161

Brand Name:

Bortezomib

Generic Name:

Bortezomib

Dosage Form Name:

INJECTION

Administration Route:

Intravenous

Substances:

Name: BORTEZOMIB

Strength: 1.0

Unit: mg/1

Packages:

Code: 70511-0161-05

Description: 1 INJECTION in 1 VIAL, SINGLE-DOSE (70511-161-05)

Effective Date: Aug. 11, 2022

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Proteasome Inhibitor

Minor Class:

26S

Orphan Drug Designation:

Status:

In Use